Burning Rock Biotech Limited
Burning Rock Biotech Limited (BNR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BNR · as of Jun 9, 2026
Key Statistics
Explore Burning Rock Biotech Limited Data
bnr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
bnr competitorsBNR
ADVB
AEMD
ALUR
AMS
AYTUStock Performance
Full HistoryAbout Burning Rock Biotech Limited
Burning Rock Biotech Limited Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the P…
what is burning rock biotech limited · bnr stock overview · burning rock biotech limited company profile · who is burning rock biotech limited ceo · bnr NASDAQ · burning rock biotech limited headquarters · burning rock biotech limited business segments
About Stock Overview & Key Data
Burning Rock Biotech Limited (BNR) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jun 12, 2020. As of the latest trading session, BNR stock price is $9.07, with a market capitalization of $9.6M. The stock has returned +200.33% over the past 12 months and -54.99% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Burning Rock Biotech Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Burning Rock Biotech Limited reported revenue of $539.6M and net income of -$55.3M. For detailed data — including Burning Rock Biotech Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Burning Rock Biotech Limited (BNR) stock price is $9.07. The stock is traded on NASDAQ under the ticker symbol BNR. The 52-week range is $2.95 – $41.72.